Orthofix International NV (OFIX) : Algert Global scooped up 29,516 additional shares in Orthofix International NV during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 12, 2016. The investment management firm now holds a total of 46,614 shares of Orthofix International NV which is valued at $1,854,305.Orthofix International NV makes up approximately 0.54% of Algert Global’s portfolio.
Other Hedge Funds, Including , Dorsey Wright Associates boosted its stake in OFIX in the latest quarter, The investment management firm added 3,581 additional shares and now holds a total of 12,443 shares of Orthofix International NV which is valued at $504,564. Orthofix International NV makes up approx 0.25% of Dorsey Wright Associates’s portfolio. Cutler Group Lp sold out all of its stake in OFIX during the most recent quarter. The investment firm sold 185 shares of OFIX which is valued $7,502.Bnp Paribas Arbitrage Sa boosted its stake in OFIX in the latest quarter, The investment management firm added 1,042 additional shares and now holds a total of 3,114 shares of Orthofix International NV which is valued at $126,242.
Orthofix International NV closed down -0.77 points or -1.90% at $39.78 with 1,42,860 shares getting traded on Tuesday. Post opening the session at $40.55, the shares hit an intraday low of $39.72 and an intraday high of $40.58 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.
On the company’s financial health, Orthofix International NV reported $0.41 EPS for the quarter, beating the analyst consensus estimate by $ 0.08 according to the earnings call on Aug 1, 2016. Analyst had a consensus of $0.33. The company had revenue of $104.08 million for the quarter, compared to analysts expectations of $102.40 million. The company’s revenue was up 3.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.36 EPS.
Orthofix International N.V. (Orthofix) is a diversified global medical device company focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians across the world. The company operates in four segments: BioStim Biologics Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim Spinal-Stim and Physio-Stim. Its Biologic solutions products include AlloQuent Structural Allografts Trinity ELITE and Trinity Evolution among others. Its Extremity Fixation solutions include Fixator and Galaxy Fixation System among others. Its Spine Fixation solutions products include NewBridge Laminoplasty Fixation System and PILLAR PL & TL PEEK VBR System among others. It uses independent distributors as well as directly distributes its products in the United States Italy the United Kingdom Germany Switzerland Austria France Brazil Australia and Puerto Rico.